France approves antibody therapy for high-risk COVID cases
France pushes vaccination campaign as virus cases increase
12 December 2021New asthma drug helps kids, but price tag is high
12 December 2021France approves antibody therapy for high-risk COVID cases
French health authorities have approved the use of an anti-body treatment made by AstraZeneca for high-risk people who show resistance to vaccines against coronavirus.
